Compare · EW vs FGI
EW vs FGI
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and FGI Industries Ltd. (FGI): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while FGI operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $50.78B, about 3501.2x FGI ($14.5M).
- EW has hit the wire 5 times in the past 4 weeks while FGI has been quiet.
- EW has more recent analyst coverage (25 ratings vs 2 for FGI).
- Company
- Edwards Lifesciences Corporation
- FGI Industries Ltd.
- Price
- -
- -
- Market cap
- $50.78B
- $14.5M
- 1M return
- -1.84%
- -
- 1Y return
- +16.04%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 2
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
FGI Industries Ltd.
FGI Industries ltd. supplies kitchen and bath products in the United States, Canada, and Europe. The company sells sanitaryware products, such as toilets, sinks, pedestals, and toilet seats; wood and wood-substitute furniture for bathrooms, including vanities, mirrors, laundry, medicine cabinets, and other storage systems; shower systems; and customer kitchen cabinetry and other accessory items under the Foremost, avenue, contrac, Jetcoat, rosenberg, and Covered Bridge Cabinetry brand names. It sells its products through mass retail centers, wholesale and commercial distributors, online retailers, independent dealers, and distributors. The company was incorporated in 2021 and is headquartered in East Hanover, New Jersey. FGI Industries Ltd. is a subsidiary of Foremost Groups Ltd.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest FGI
- SEC Form 10-Q filed by FGI Industries Ltd.
- FGI Industries Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- FGI INDUSTRIES ANNOUNCES SECOND QUARTER 2026 RESULTS
- FGI INDUSTRIES ANNOUNCES SECOND QUARTER RESULTS CONFERENCE CALL DATE
- FGI Industries Ltd. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by FGI Industries Ltd.
- FGI Industries Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- FGI INDUSTRIES ANNOUNCES FIRST QUARTER 2026 RESULTS
- SEC Form SD filed by FGI Industries Ltd.
- SEC Form DEF 14A filed by FGI Industries Ltd.